| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 814.71B | 764.81B | 736.56B | 692.16B | 611.63B |
| Gross Profit | 300.15B | 275.30B | 261.01B | 239.83B | 216.07B |
| EBITDA | 205.78B | 182.74B | 167.09B | 154.67B | 144.60B |
| Net Income | 15.26B | 93.76B | 79.64B | 76.31B | 71.44B |
Balance Sheet | |||||
| Total Assets | 959.79B | 928.50B | 922.77B | 838.22B | 789.65B |
| Cash, Cash Equivalents and Short-Term Investments | 132.62B | 168.60B | 173.94B | 129.26B | 115.61B |
| Total Debt | 236.13B | 271.02B | 298.54B | 237.74B | 250.42B |
| Total Liabilities | 521.79B | 490.54B | 519.75B | 435.81B | 447.17B |
| Stockholders Equity | 433.90B | 434.04B | 399.53B | 399.01B | 339.36B |
Cash Flow | |||||
| Free Cash Flow | 141.80B | 123.54B | 134.79B | 106.84B | 91.31B |
| Operating Cash Flow | 147.64B | 130.20B | 142.28B | 118.90B | 98.14B |
| Investing Cash Flow | -97.05B | -47.59B | -53.98B | -61.19B | -130.55B |
| Financing Cash Flow | -90.78B | -87.31B | -47.02B | -44.92B | -8.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥69.98B | 3.15 | ― | 3.28% | 12.54% | 171.52% | |
67 Neutral | ¥394.61B | 12.46 | ― | 2.17% | 7.35% | 17.48% | |
64 Neutral | ¥763.29B | 20.55 | ― | 1.39% | 5.45% | 7.26% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥652.55B | 17.25 | 10.07% | 1.76% | 12.72% | 13.98% | |
59 Neutral | ¥2.38T | -9.13 | 22.48% | 1.14% | 6.52% | -83.73% |